CWChristopher Walton

Christopher Walton

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Christopher Walton has a total of 201 co-authors. Here are the top co-authors by number of shared publications:

  • Ian F. Godsland

    From the Wynn Department of Metabolic Medicine, Imperial College School of Medicine at the National Heart and Lung Institute (F.L., I.F.G., A.J.P., C.W., S.A., J.C.S.); and the Department of Endocrinology, Imperial College School of Medicine, Hammersmith Campus (M.G., S.B.), London, UK

    7 shared publications
  • John C. Stevenson

    Faculty of Medicine, Endocrinology and Metabolic Medicine, Imperial College London, London, UK

    7 shared publications
  • David Crook

    Clinical Investigations and Research Unit, Royal Sussex County Hospital, Sussex, UK

    6 shared publications
  • Dawn P. Fowler

    Environmental Analytical Facility, Cranfield University, Cranfield, Bedfordshire, MK43 0AL, UK

    5 shared publications
  • V. Wynn

    5 shared publications
  • Claire Turner

    Open University

    4 shared publications

Latest Publications

  • Open Access

    Exposure to benzene, toluene, ethylbenzene, and xylene (BTEX) at Nigeria's petrol stations: a review of current status, challenges and future directions

    by Emmanuel Ademola Anigilaje, Zaheer Ahmad Nasir, Christopher Walton

    Introduction: In Nigeria, because of increasing population, urbanization, industrialization, and auto-mobilization, petrol is the most everyday non-edible commodity, and it is the leading petroleum product traded at the proliferating Nigeria's petrol stations (NPSs). However, because of inadequate occupational health and safety (OHS) regulatory measures, working at NPSs exposes petrol station workers (PSWs) to a large amount of hazardous benzene, toluene, ethylbenzene, and xylene (BTEX) compounds.Methods: Studies on BTEX exposures among Nigerian PSWs are scarce. Thus, constraints in quantifying the health risks of BTEX limit stakeholders' ability to design practical risk assessment and risk control strategies. This paper reviews studies on the OHS of Nigerian PSWs at the NPSs.Results: Although knowledge, attitude, and practices on OHS in NPSs vary from one Nigeria's study setting to another, generally, safety practices, awareness about hazards and personal protective equipment (PPE), and the use of PPE among PSWs fell below expectations. Additionally, air quality at NPSs was poor, with a high content of BTEX and levels of carbon monoxide, hydrogen sulfide, particulate matter, and formaldehyde higher than the World Health Organization guideline limits.Discussion: Currently, regulatory bodies' effectiveness and accountability in safeguarding OHS at NPSs leave much to be desired. Understanding the OHS of NPSs would inform future initiatives, policies, and regulations that would promote the health and safety of workers at NPSs. However, further studies need to be conducted to describe the vulnerability of PSWs and other Nigerians who are occupationally exposed to BTEX pollution. More importantly, controlling air pollution from hazardous air pollutants like BTEX is an essential component of OHS and integral to attaining the Sustainable Development Goals (SDG) 3, 7, and 11.


  • 906-P: The Association of British Clinical Diabetologists Audit of Freestyle Libre (FSL) in Diabetes in United Kingdom: Determinants of Time-in-Target Range

    by Emma G. Wilmot, Harshal Deshmukh, Jane Patmore, Thozhukat Sathyapalan, Christopher Walton, Roselle Herring, Robert E. Ryder

    Objective: Time in range (TIR) is a novel measure of glucose control endorsed by an international consensus group. TIR describes the percentage of TIR (3.9-10mmol/l), time above range (TAR >10mmol/l) and time below range (TBR, <3.9mmol/l) over a given time period. Given the increased use of FreeStyle Libre (FSL) in the UK we were keen to explore the glucose ranges commonly reported in routine clinical practice. Methods: The ABCD UK FreeStyle Libre audit invited clinicians to submit routine clinical data from FSL users to a secure web-based tool. Data from 101 UK hospitals were analysed using R3.5.0. Linear regression analysis was used to compare the baseline predictors of TIR . TIR was categorised as internationally accepted (3.9-10mmol/l) or individualised (any range other than 3.0-10mmol/l). Results: Data were available for 10,370 FSL users; age 38 (±18.7) years, 54% female, diabetes duration 16 (±49) years, and BMI of 25.2 (±16.5) kg/m2. Follow-up HbA1c and TIR data was available for 2191 patients. Of those with both follow-up HbA1c and TIR data, in only 343 (15%) cases did clinicians report on the internationally accepted TIR (3.9-10mmol/l), with a median TIR of 43% (27%-56%). Taking both international and individualised TIR together, 221 (10%) had ≥70% TIR, 822 (37%) ≥50% TIR and 1372 (62%) <50% TIR over 14 days. On multivariate regression analysis baseline age (beta=0.13 P<0.0001, number of FSL scans per day (beta= 0.22, P<0.0001) and baseline HbA1c (beta=-0.45, P<0.0001) were associated with higher TIR. The internationally accepted median TBR (<3.9mmol/l) was 6% (3-11) in this cohort. Conclusion: This population-based study of FSL users demonstrates a limited uptake of the internationally recommended TIR of 3.9-10mmol/l. There is a need for greater awareness of the international recommendations for TIR measures; only a small proportion of people with type 1 diabetes achieve their goals; the number of scans per day predicts greater TIR. Disclosure: E.G. Wilmot: Advisory Panel; Self; Abbott, Dexcom, Inc., Eli Lilly and Company, Insulet Corporation, Medtronic. Speaker’s Bureau; Self; Abbott, Eli Lilly and Company, Insulet Corporation, Novo Nordisk Inc., Sanofi. H. Deshmukh: None. J. Patmore: None. T. Sathyapalan: Research Support; Self; Amgen, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Novo Nordisk A/S. Other Relationship; Self; Ipsen Biopharmaceuticals. C. Walton: Speaker’s Bureau; Spouse/Partner; Celgene, LEO Pharma, Novartis Pharmaceuticals Corporation. R. Herring: None. R.E. Ryder: Consultant; Self; GI Dynamics Inc. Other Relationship; Self; Novo Nordisk A/S.


  • Open Access

    Instrumentation for quantitative analysis of volatile compounds emission at elevated temperatures. Part 1: Design and implementation

    by Célia Lourenço, Sarah Bergin, Jane Hodgkinson, Daniel Francis, Stephen E. Staines, John R. Saffell, Christopher Walton, Ralph P. Tatam

    A novel suite of instrumentation for the characterisation of materials held inside an air-tight tube furnace operated up to 250 °C has been developed. Real-time detection of released gases (volatile organic compounds (VOCs), CO2, NO, NO2, SO2, CO and O2) was achieved combining commercial off-the-shelf (COTS) gas sensors and sorbent tubes for further qualitative and semi-quantitative analysis by gas chromatography-mass spectrometry coupled to thermal desorption (TD-GC-MS). The test system was designed to provide a controlled flow (1000 cm3 min−1) of hydrocarbon free air through the furnace. The furnace temperature ramp was set at a rate of 5 °C min−1 with 10 min dwell points at 70 °C, 150 °C, 200 °C and 250 °C to allow time for stabilisation and further headspace sampling onto sorbent tubes. Experimental design of the instrumentation is described here and an example data set upon exposure to a gas sample is presented.


  • Open Access

    Instrumentation for quantitative analysis of volatile compounds emission at elevated temperatures. Part 2: Analysis of carbon fibre reinforced epoxy composite

    by Célia Lourenço, Daniel Francis, Dawn P. Fowler, Stephen E. Staines, Jane Hodgkinson, Christopher Walton, Sarah Bergin, Ralph P. Tatam

    We have investigated the release of gases and volatile organic compounds (VOCs) from a carbon fibre reinforced epoxy composite matrix used in aircraft structural components. Analysis was performed at several temperatures both up to and above the recommended operating temperature (121 °C) for the material, to a maximum of 250 °C. Gas chromatography-mass spectrometry (GC-MS) combined with thermal desorption (TD-GC-MS) was used to identify and quantify VOCs, and in parallel real-time gas detection with commercial off-the-shelf (COTS) gas sensors. Under hydrocarbon free air, CO, SO2, NO, NO2and VOCs (mainly aldehydes, ketones and a carboxylic acid) were detected as the gaseous products released during the thermal exposure of the material up to 250 °C, accompanied by increased relative humidity (4%). At temperatures up to 150 °C, gas and volatile emission was limited.


  • Open Access

    Faecal volatile biomarkers of Clostridium difficile infection

    by Mitesh Patel, Dawn Fowler, Jeremy Sizer, Christopher Walton

    Care of patients with potential CDI can involve isolation and use of antibiotics, often before a definitive diagnosis is available, impacting healthcare resource and contributing to antibiotic resistance. There is anecdotal evidence that the faeces of CDI patients have a distinctive odour, while it is well-established that changes in the gut microbiota are associated with changes in the volatile organic compounds (VOC) produced. A total of twenty-four candidate volatile biomarkers were identified from a review of the literature including in vitro, animal and human studies. Using thermal desorption-gas chromatography-time-of flight mass spectrometry (TD-GC-ToFMS), VOC emission rates were determined on stored frozen stool samples from 53 CDI-positive and 53 CDI-negative patients with unexplained diarrhoea which had previously been diagnosed using enzymatic and nucleic acid amplification tests. Sample preparation was limited to placement of a subsample in an appropriate container. Compounds exhibiting a statistically significant difference (p < 0.05) in emission rate between the CDI-positive and–negative groups and a corresponding area under the receiver-operator characteristic curve (ROC) >0.7 were considered potentially indicative of CDI. Seven compounds were so identified: propan-1-ol (ROC 0.75), 3-methylbutanal (ROC 0.84), ethyl propionate (ROC 0.81), hexanoic acid (ROC 0.73), 4-methylphenol (ROC 0.81), dodecane (ROC 0.80) and indole (ROC 0.85). A number of potential volatile biomarkers of CDI can be sampled rapidly and with little prior preparation from faecal samples of patients with diarrhoea. Of these 4-methylphenol (p-cresol) is of particular interest as it has been anecdotally linked to CDI and is closely related to the biology and virulence of Clostridium difficile. This approach shows promise for the rapid, point-of-care diagnosis of CDI with good sensitivity and specificity.


  • Open Access

    Quantification of liquid phase faecal odourants to evaluate membrane technology for wastewater reuse from decentralised sanitation facilities

    by E. Mercer, C. J. Davey, P. Campo, D. Fowler, L. Williams, A. Kolios, A. Parker, S. Tyrrel, C. Walton, E. Cartmell, et al.

    Public willingness to use decentralised sanitation facilities or arising water products is discouraged due to malodour, preventing improved sanitation practices or water reuse opportunities in low income countries. Whilst odour is characterised in the gas phase, it originates in the liquid phase. Consequently, controlling odour at source could prevent gas-phase partitioning and limit produced water contamination. This study therefore developed an analytical method for the quantitation of a range of liquid phase volatile organic compounds (VOCs) classified into eight chemical groups, known to be primary indicators of faecal odour, to provide characterisation of real fluids and to permit evaluation of several potential membrane separation technologies for liquid phase odourant separation. The gas chromatography mass spectrometry method provided quantitation in the range of 0.005 mg L−1 to 100 mg L−1 with instrument detection limits ranging from 0.005 mg L−1 to 0.124 mg L−1. Linear calibration curves were achieved (r2 > 0.99) with acceptable accuracy (77–115%) and precision (−1, and good accuracy (98–104%) and precision (−1. Pre-concentration of real samples was facilitated via solid phase extraction. Subsequent application of the method to the evaluation of two thermally driven membranes based on hydrophilic (polyvinyl alcohol) and hydrophobic (polydimethylsiloxane) polymers evidenced contrasting separation profiles. Importantly, this study demonstrates the method's utility for liquid phase VOC determination which is of use to a range of disciplines, including healthcare professionals, taste and odour specialists and public health engineers.


  • Mid-IR spectroscopic instrumentation for point-of-care diagnosis using a hollow silica waveguide gas cell

    by Daniel Francis, Jane Hodgkinson, Christopher Walton, Jeremy Sizer, Paul Black, Beth Livingstone, Dawn P. Fowler, Mitesh K. Patel, Ralph P. Tatam


  • Open Access

    Enteral feeding reduces metabolic activity of the intestinal microbiome in Crohn’s disease: an observational study

    by C Walton, M P B Montoya, D P Fowler, C Turner, W Jia, R N Whitehead, L Griffiths, R H Waring, D B Ramsden, J A Cole, et al.

    Enteral feeding will induce remission in as many as 80–90% of compliant patients with active Crohn’s disease (CD), but its method of action remains uncertain. This study was designed to examine its effects on the colonic microbiome. Healthy volunteers and patients with CD followed a regimen confined to enteral feeds alone for 1 or 2 weeks, respectively. Chemicals excreted on breath or in faeces were characterised at the start and at the end of the feeding period by gas chromatography/mass spectrometry. One week of feeding in healthy volunteers caused significant changes in stool colour and deterioration in breath odour, together with increased excretion of phenol and indoles on the breath. Feeding for 2 weeks in patients with CD produced significant improvements in symptoms and a decrease in the concentration of C-reactive protein. The faecal concentrations of microbial products, including short-chain fatty acids (SCFAs), and potentially toxic substances, including 1-propanol, 1-butanol and the methyl and ethyl esters of SCFAs, showed significant falls. A significant change occurs in the production of microbial metabolites after enteral feeding in both healthy volunteers and patients with CD. Many of those detected in CD are toxic and may feasibly lead to the immunological attack on the gut microbiota, which is characteristic of inflammatory bowel disease. The reduction in the production of such metabolites after enteral feeding may be the reason for its effectiveness in CD.


  • Open Access

    A novel method for the analysis of clinical biomarkers to investigate the effect of diet on health in a rat model

    by K. Hopes, M. Cauchi, C. Walton, H. MacQueen, W. Wassif, C. Turner

    Experiments into the relationship between diet and health have been an area of high interest for a long time. In this study, we investigate the application of multivariate data analysis to differentiate between rat populations fed on two different diets: normal rat diet (control) and Western affluent diet (WAD). Two sets of data were acquired and analysed: one from a biochemical clinical analyser, taking measurements of blood-based biochemical markers; the other from the analysis of the volatile organic compounds (VOCs) emitted from faecal samples from the same animals using selected ion flow tube mass spectrometry (SIFT-MS). Five classes were considered: weanlings, 12 month controls, 12 month WADs, 18 month controls, and 18 month WADs. Data from the biochemical analyser, weanlings and 18 month WAD fed rats showed significant differences from the other measurement classes. This was shown in both the exploratory analysis and through multivariate classification. Classification of control diet versus WAD diets suggested there are differences between classes with 92% accuracy for the 12 month classes and 91% for the 18 month classes. Cholesterol markers, especially as low density lipoprotein-cholesterol (LDL), were the main factor in influencing WAD samples. The data from the SIFT-MS analysis also produced very good classification accuracies. Classification of control diet versus WAD diets using the H3O+ precursor ion data suggested there are differences between classes with 71% accuracy for the 12 month classes and 100% for the 18 month classes. These findings confirm that total cholesterol and LDL-cholesterol are elevated in the 18 month WAD-fed rats. We therefore suggest that the analysis of VOCs from faecal samples in conjunction with multivariate data analysis may be a useful alternative to blood analysis for the detection of parameters of health.


  • The use of a portable breath analysis device in monitoring type 1 diabetes patients in a hypoglycaemic clamp: validation with SIFT-MS data

    by C Walton, M Patel, D Pitts, P Knight, S Hoashi, M Evans, C Turner

    Monitoring blood glucose concentrations is a necessary but tedious task for people suffering from diabetes. It has been noted that breath in people suffering with diabetes has a different odour and thus it may be possible to use breath analysis to monitor the blood glucose concentration. Here, we evaluate the analysis of breath using a portable device containing a single mixed metal oxide sensor during hypoglycaemic glucose clamps and compare that with the use of SIFT-MS described in previously published work on the same set of patients. Outputs from both devices have been correlated with the concentration of blood glucose in eight volunteers suffering from type 1 diabetes mellitus. The results demonstrate that acetone as measured by SIFT-MS and the sensor output from the breath sensing device both correlate linearly with blood glucose; however, the sensor response and acetone concentrations differ greatly between patients with the same blood glucose. It is therefore unlikely that breath analysis can entirely replace blood glucose testing.